骨科指南

订阅

MedSci主页 / 所有栏目 / 骨科指南

2017 SIOT临床指南：骨质疏松症的预防和治疗

2017-10-20 意大利骨科和创伤外科学会 J Orthop Traumatol. 2017 Oct 20.

骨质疏松症

2017年10月，意大利骨科和创伤外科学会(SIOT)发布了骨质疏松症的预防和治疗指南，指南主要针对骨质疏松及其影响的诊断，预防以及治疗等内容提供指导建议，内容涉及骨质疏松的定义，主要类型，诊断，骨折风险评估和危险因素，骨质疏松症的一般预防和治疗，药物治疗，二级预防等。

中文标题：

2017 SIOT临床指南：骨质疏松症的预防和治疗

英文标题：

Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology.

发布机构：

意大利骨科和创伤外科学会

发布日期：

2017-10-20

简要介绍：

2017年10月，意大利骨科和创伤外科学会(SIOT)发布了骨质疏松症的预防和治疗指南，指南主要针对骨质疏松及其影响的诊断，预防以及治疗等内容提供指导建议，内容涉及骨质疏松的定义，主要类型，诊断，骨折风险评估和危险因素，骨质疏松症的一般预防和治疗，药物治疗，二级预防等。

 

拓展指南：与骨质疏松相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 SIOT临床指南：骨质疏松症的预防和治疗)] GetToolGuiderByIdResponse(projectId=1, id=0ccd11c00151a48a, title=2017 SIOT临床指南：骨质疏松症的预防和治疗, enTitle=Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology., guiderFrom=J Orthop Traumatol. 2017 Oct 20., authorId=null, author=, summary=2017年10月，意大利骨科和创伤外科学会(SIOT)发布了骨质疏松症的预防和治疗指南，指南主要针对骨质疏松及其影响的诊断，预防以及治疗等内容提供指导建议，内容涉及骨质疏松的定义，主要类型，诊断，骨折风险评估和危险因素，骨质疏松症的一般预防和治疗，药物治疗，二级预防等。 , cover=, journalId=null, articlesId=null, associationId=1539, associationName=意大利骨科和创伤外科学会, associationIntro=, copyright=0, guiderPublishedTime=Fri Oct 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年10月，意大利骨科和创伤外科学会(SIOT)发布了骨质疏松症的预防和治疗指南，指南主要针对骨质疏松及其影响的诊断，预防以及治疗等内容提供指导建议，内容涉及骨质疏松的定义，主要类型，诊断，骨折风险评估和危险因素，骨质疏松症的一般预防和治疗，药物治疗，二级预防等。 </P> <P> </P>拓展指南：<STRONG>与<FONT color=red>骨质疏松</FONT>相关指南：</STRONG><BR> <UL> <LI><A title=原发性骨质疏松症诊疗指南(2017版)要点解读 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=844791c00150e9e1">原发性骨质疏松症诊疗指南(2017版)要点解读</A> <LI><A title=原发性骨质疏松症诊疗指南（2017） target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=6311a1c00150e884">原发性骨质疏松症诊疗指南（2017）</A> <LI><A title="2017 ACR指南：糖皮质激素诱发的骨质疏松症的预防和治疗" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=dc9641c001a50599">2017 ACR指南：糖皮质激素诱发的骨质疏松症的预防和治疗</A> <LI><A title="2017 EMAS立场声明：双磷酸盐类药物假期和地诺单抗治疗绝经后骨质疏松症" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=220f71c001a4450c">2017 EMAS立场声明：双磷酸盐类药物假期和地诺单抗治疗绝经后骨质疏松症</A> <LI><A title="2017 ACR适宜性标准：骨质疏松症和骨密度" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=fab8c1c001a425ed">2017 ACR适宜性标准：骨质疏松症和骨密度</A> 更多信息请点击：<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E9%AA%A8%E8%B4%A8%E7%96%8F%E6%9D%BE">有关骨质疏松更多指南</A></LI></UL>, tagList=[TagDto(tagId=644, tagName=骨质疏松症)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21067, categoryName=梅斯医学-骨质疏松网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6877, appHits=440, showAppHits=0, pcHits=4996, showPcHits=1933, likes=218, shares=16, comments=6, approvalStatus=1, publishedTime=Thu Nov 02 22:02:32 CST 2017, publishedTimeString=2017-10-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Nov 02 22:02:32 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 17:18:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 SIOT临床指南：骨质疏松症的预防和治疗)])
2017 SIOT临床指南：骨质疏松症的预防和治疗
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=958381, encodeId=682f9583817a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/acdea1e4c28844b3918f4e45cd8d2351/d3bd69afec794f9a94af8da583ae4ab3.jpg, createdBy=36785482047, createdName=ms1000000157062026, createdTime=Mon Apr 19 15:12:12 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265947, encodeId=efb226594efa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2152211931, createdName=120d8e71m70暂无昵称, createdTime=Fri Dec 01 12:32:39 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258292, encodeId=8a8825829233, content=学习了谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6831717982, createdName=微分, createdTime=Fri Nov 03 08:15:02 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258291, encodeId=47b825829158, content=学习了谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6831717982, createdName=微分, createdTime=Fri Nov 03 08:14:56 CST 2017, time=2017-11-03, status=1, ipAttribution=)]
    2021-04-19 ms1000000157062026

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=958381, encodeId=682f9583817a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/acdea1e4c28844b3918f4e45cd8d2351/d3bd69afec794f9a94af8da583ae4ab3.jpg, createdBy=36785482047, createdName=ms1000000157062026, createdTime=Mon Apr 19 15:12:12 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265947, encodeId=efb226594efa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2152211931, createdName=120d8e71m70暂无昵称, createdTime=Fri Dec 01 12:32:39 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258292, encodeId=8a8825829233, content=学习了谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6831717982, createdName=微分, createdTime=Fri Nov 03 08:15:02 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258291, encodeId=47b825829158, content=学习了谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6831717982, createdName=微分, createdTime=Fri Nov 03 08:14:56 CST 2017, time=2017-11-03, status=1, ipAttribution=)]
    2017-12-01 120d8e71m70暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=958381, encodeId=682f9583817a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/acdea1e4c28844b3918f4e45cd8d2351/d3bd69afec794f9a94af8da583ae4ab3.jpg, createdBy=36785482047, createdName=ms1000000157062026, createdTime=Mon Apr 19 15:12:12 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265947, encodeId=efb226594efa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2152211931, createdName=120d8e71m70暂无昵称, createdTime=Fri Dec 01 12:32:39 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258292, encodeId=8a8825829233, content=学习了谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6831717982, createdName=微分, createdTime=Fri Nov 03 08:15:02 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258291, encodeId=47b825829158, content=学习了谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6831717982, createdName=微分, createdTime=Fri Nov 03 08:14:56 CST 2017, time=2017-11-03, status=1, ipAttribution=)]
    2017-11-03 微分

    学习了谢谢作者分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=958381, encodeId=682f9583817a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/acdea1e4c28844b3918f4e45cd8d2351/d3bd69afec794f9a94af8da583ae4ab3.jpg, createdBy=36785482047, createdName=ms1000000157062026, createdTime=Mon Apr 19 15:12:12 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265947, encodeId=efb226594efa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2152211931, createdName=120d8e71m70暂无昵称, createdTime=Fri Dec 01 12:32:39 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258292, encodeId=8a8825829233, content=学习了谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6831717982, createdName=微分, createdTime=Fri Nov 03 08:15:02 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258291, encodeId=47b825829158, content=学习了谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6831717982, createdName=微分, createdTime=Fri Nov 03 08:14:56 CST 2017, time=2017-11-03, status=1, ipAttribution=)]
    2017-11-03 微分

    学习了谢谢作者分享!

    0

相关指南

原发性骨质疏松症诊疗指南(2017版)要点解读

暂未更新 · 2017-10-10

2017 ACP临床实践指南：治疗低骨密度或骨质疏松症预防骨折

美国医学会(AMA,American Medical Association) · 2017-05-09